89BIO - 53 Year Dividend History | ETNB

Historical dividend payout and yield for 89BIO (ETNB) since 1971. The current TTM dividend payout for 89BIO (ETNB) as of July 19, 2024 is $0.00. The current dividend yield for 89BIO as of July 19, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.822B $0.000B
89bio Inc. is clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is being developed for the treatment of nonalcoholic steatohepatitis. 89bio Inc. is headquartered in San Francisco.
Stock Name Country Market Cap PE Ratio